2020 Best of Breast

 

Videos
19:20

2020 Best of Breast

Case of 54 y/o F With Metastatic Breast Cancer: Eligibility for Genetic Testing & Data on Olaparib and Talazoparib for Pts With Germline BRCA Mutations

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 125 views
  • March 20, 2020
  • 1
11:26

2020 Best of Breast

Case of 54 y/o F With Metastatic Breast Cancer: Altering Treatment Plan Bc the Somatic and Germline Testing Was Not Concordant? & Why Is Important to Know Both the Germline and Somatic Results?

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 90 views
  • March 20, 2020
  • 1
23:49

2020 Best of Breast

Case of 53 y/o Post-menopausal F With TNBC Who Undergoes Genetic Testing: RAD51 Mutation, Incorporating Platinum in the Neoadjuvant Setting & PARPi in the Metastatic and Curative Setting

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 368 views
  • March 20, 2020
  • 5
19:58

2020 Best of Breast

Case of 53 y/o Post-menopausal F With TNBC and Mutations in RAD51: Cascade Testing & Recommended Management of BRCA 1/2 Mutation

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 80 views
  • March 20, 2020
20:08

2020 Best of Breast

Treatment of 45 y/o With CHEK2 Mutated Breast Cancer: Screening Guidelines for High Risk Pts

FEATURING Kristina Mirabeau-Beale, Bolivar Arboleda, Jennifer Klemp, Monica Yepes, Jane Meisel, Miguel A. Medina, Wendy K. Chung
  • 177 views
  • March 20, 2020
  • 2
13:53

2020 Best of Breast

Decision Making in Early Stage BC - Case of 36 y/o Pre-Menopausal Woman: Is There a Role for Breast MRI? Considering Neoadjuvant Therapy? Using Genomic Test to Determine Benefit of Chemo?

FEATURING Kevin Kalinsky
  • 100 views
  • March 2, 2020
  • 1
12:13

2020 Best of Breast

Decision Making in Early Stage Breast Cancer - Case of 36 y/o Pre-Menopausal Woman: Using Anthracycline Chemo? Data from ABC Trials - The TaxAC Regimens Improved IDFS

FEATURING Kevin Kalinsky
  • 52 views
  • March 2, 2020
29:23

2020 Best of Breast

Decision Making in Early Stage Breast Cancer - Case of 36 y/o Pre-Menopausal Woman: Scalp Cooling Benefits, Post-Mastectomy Radiation, Which Adjuvant Hormonal Therapy Is Recommended, Long Term Adherence to AET, Fertility Preservation

FEATURING Kevin Kalinsky
  • 48 views
  • March 2, 2020
15:25

2020 Best of Breast

Decision Making in Early Stage Breast Cancer - Late Recurrence and Genomic Assay Data: Trials of TAM + Al and Extended Al & BCI Predicts Benefit from Extended Tamoxifen

FEATURING Kevin Kalinsky
  • 162 views
  • March 2, 2020
  • 1
10:26

2020 Best of Breast

Combating Endocrine Resistance in Breast Cancer: Side Effects Management & Suppression of Ovarian Function With Tamoxifen Significantly Improves DFS

FEATURING Reshma L. Mahtani
  • 24 views
  • March 2, 2020
12:07

2020 Best of Breast

Treatment of 52 y/o Post-Menopausal Woman HER2- Breast Cancer & Bone Mets: Clinical Significance of Loco-Regional Recurrence & Data on Stereotactic Ablative Radiotherapy

FEATURING Reshma L. Mahtani, Laura Freedman, Ruta Rao, Terry Mamounas
  • 24 views
  • March 2, 2020
15:10

2020 Best of Breast

Discussion on Systemic Treatment Algorithm for HR+, HER2- Recurrent Breast Cancer: Review of Approved CDK4/6 Inhibitors and Related Trials, Differences in Dosing and Safety & Managing Side Effects

FEATURING Reshma L. Mahtani, Ruta Rao, Kevin Kalinsky, Shirley Godbold
  • 58 views
  • March 2, 2020
13:39

2020 Best of Breast

Treatment of Post-Menopausal Woman in the 2nd Line Setting After Progression on CDK4/6 and AI: Data on Alpelisib + Fulvestrant and Other Treatment Options & PARP Inhibitors for gBRCA Mutated BC

FEATURING Reshma L. Mahtani
  • 482 views
  • March 2, 2020
  • 3
13:25

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer: Repeating HER2 Testing on Surgical Specimen & Data on HER2 ISH Testing Using a Dual-Probe Assay

FEATURING Reshma L. Mahtani, Kristina Mirabeau-Beale, Sunil Badve, Jane Meisel, Jorge Flores
  • 212 views
  • March 2, 2020
  • 2
14:48

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer - Options for Early Stage Disease: Discussing Data on Paclitaxel/Trastuzumab, T-DM1, & Pertuzumab and Trastuzumab

FEATURING Reshma L. Mahtani
  • 951 views
  • March 2, 2020
  • 4
17:17

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer: Consulting Cardiologist for Asymptomatic Drops in EF During Adjuvant Trastuzumab, Radiation Considerations to Optimize Therapy & Taxane-Induced Neuropathy

FEATURING Reshma L. Mahtani
  • 14 views
  • March 2, 2020
09:36

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman With HER2+ Breast Cancer and Developed Brain Mets: Gamma Knife for Brain Lesions, 2nd Line Therapy With Neratinib + Xeloda & New Data on Tucatinib Show Significant Progress

FEATURING Reshma L. Mahtani
  • 38 views
  • March 2, 2020
09:07

2020 Best of Breast

Treatment of 57 y/o Post-Menopausal Woman with HER2+ Breast Cancer and Progression in Liver - Data on Durable Efficacy of Trastuzumab Deruxtecan

FEATURING Reshma L. Mahtani
  • 247 views
  • March 2, 2020
  • 1
33:37

2020 Best of Breast

Treatment Options for 55 y/o Woman With T2, Node Negative TNBC: Neoadjuvant Chemo First? Platinum or Checkpoint Inhibition + Chemo? Reviewing Data From IO Trials

FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
  • 285 views
  • March 2, 2020
  • 3
12:01

2020 Best of Breast

Treatment of 55 y/o Woman with T2, Node Negative TNBC: Checking Residual Cancer Burden Score? Considering Adjuvant Capecitabine?

FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
  • 44 views
  • March 2, 2020
13:59

2020 Best of Breast

Treatment of 55 y/o Woman with T2, Node Negative TNBC - Developing Adrenal Insufficiency After Nab-Paclitaxel + Atezolizumab, Management of Endocrinopathies & New Agents in TNBC

FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
  • 270 views
  • March 2, 2020
  • 3
25:24

2020 Best of Breast

Cardiac Oncology: Management of Cardiovascular Toxicity, Tools for the Detection and Strategies to Reduce Toxicity

FEATURING Jorge Flores
  • 14 views
  • March 2, 2020
19:43

2020 Best of Breast

Endocrinopathy Management Related to Oncologic Agents: Alpelisib and Hyperglycemia, Pembrolizumab and Hyperthyroidism

FEATURING Salila Kurra
  • 161 views
  • March 2, 2020
10:32

2020 Best of Breast

Case of 65 y/o Woman With Breast Cancer Treated With Pembro: Management of Hypothyroidism Developed After Checkpoint Inhibitor Treatment

FEATURING Salila Kurra
  • 11 views
  • March 2, 2020
20:50

2020 Best of Breast

Breast Cancer and Impact of Low Access to Innovative and Essential Medicines & High Cost Medications

FEATURING Gilberto Lopes
  • 33 views
  • March 2, 2020
  • 1
14:56

2020 Best of Breast

Cost of Developing New Drugs, Access to Innovative Cancer Drugs, & Improving Cost Effectiveness with Generics and Biosimilars

FEATURING Gilberto Lopes
  • 17 views
  • March 2, 2020